Table 4.

Distribution of GAD65 and insulin B9–23 peptide and C peptide reactive T cell in 10 Chinese FT1D patients.

Specific-reactive T cell	FT1DM (n = 10)
GAD65	7/10
Insulin B9–23 peptide	4/10
C peptide	4/10
GAD65 and insulin B9–23 peptide	3/10
GAD65 and C peptide	3/10
Insulin B9–23 peptide and C peptide	2/10
GAD, insulin B9–23 peptide, and C peptide	1/10
GAD, insulin B9–23 peptide, or C peptide	8/10